Overview

CAMEO: Canadian Methotrexate and Etanercept Outcome Study

Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of the study is to evaluate the use of etanercept in the treatment of rheumatoid arthritis with or without methotrexate treatment over a 24 month period
Phase:
Phase 4
Details
Lead Sponsor:
Amgen
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Treatments:
Etanercept
Methotrexate